Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kluft

Showing results (31-40 of 291) with videos related to

Pageof 30
Sort By:
Seminars in Vascular Medicine|November 23, 2005
The harmonization of quantitative test results of different D-dimer methodsP Meijer, C Kluft
Thrombosis and Haemostasis|June 30, 1986
Inhibition of tissue-type plasminogen activator in plasma of women using oral contraceptives and in normal women during a menstrual cycleJ Jespersen, C Kluft
Thrombosis Research|January 1, 1981
Demonstration of two forms of alpha 2-antiplasmin in plasma by modified crossed immunoelectrophoresisC Kluft, N Los
Thrombosis and Haemostasis|August 30, 1985
Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen--levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivatorJ Jespersen, C Kluft
Nucleic Acids Research|August 11, 1991
KpnI RFLP in the human histidine-rich glycoprotein geneB C Hennis, C Kluft
Clinics in Haematology|May 1, 1986
Advances in clinical fibrinolysisL W Hessel, C Kluft
Thrombosis and Haemostasis|December 29, 1984
Improved assay conditions for automated antithrombin III determinations with the chromogenic substrate S-2238H van Voorthuizen, C Kluft
Blood|February 1, 1987
Plasminogen activator inhibitorsE D Sprengers, C Kluft
Blood|July 1, 1985
PAF-acether-induced release of tissue-type plasminogen activator from vessel wallsJ J Emeis, C Kluft
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|April 18, 2001
Determination of the habitual low blood level of C-reactive protein in individualsC Kluft, M P de Maat
Pageof 30

Showing results (31-40 of 291) with videos related to

Sort By:
Pageof 30
Seminars in Vascular Medicine|November 23, 2005
The harmonization of quantitative test results of different D-dimer methodsP Meijer, C Kluft
Thrombosis and Haemostasis|June 30, 1986
Inhibition of tissue-type plasminogen activator in plasma of women using oral contraceptives and in normal women during a menstrual cycleJ Jespersen, C Kluft
Thrombosis Research|January 1, 1981
Demonstration of two forms of alpha 2-antiplasmin in plasma by modified crossed immunoelectrophoresisC Kluft, N Los
Thrombosis and Haemostasis|August 30, 1985
Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen--levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivatorJ Jespersen, C Kluft
Nucleic Acids Research|August 11, 1991
KpnI RFLP in the human histidine-rich glycoprotein geneB C Hennis, C Kluft
Clinics in Haematology|May 1, 1986
Advances in clinical fibrinolysisL W Hessel, C Kluft
Thrombosis and Haemostasis|December 29, 1984
Improved assay conditions for automated antithrombin III determinations with the chromogenic substrate S-2238H van Voorthuizen, C Kluft
Blood|February 1, 1987
Plasminogen activator inhibitorsE D Sprengers, C Kluft
Blood|July 1, 1985
PAF-acether-induced release of tissue-type plasminogen activator from vessel wallsJ J Emeis, C Kluft
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|April 18, 2001
Determination of the habitual low blood level of C-reactive protein in individualsC Kluft, M P de Maat
Pageof 30